High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study

Peptides

Volumn 61, Issue , 2014, Pages 122-129

  Laurila, M ^a,b   Santaniemi, M ^a,b   Kesaniemi Y A ^a,b   Ukkola, O ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b MEDICAL RESEARCH CENTER OULU   (Finland)

Author keywords

Cancer; Cardiovascular disease; Coronary heart disease; Ghrelin; Ghrelin polymorphism

Indexed keywords

GHRELIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CANCER GENETICS; CANCER PREVENTION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENOTYPE; HEART PROTECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; AMINO ACID SUBSTITUTION; BLOOD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MISSENSE MUTATION; NEOPLASM; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMINO ACID SUBSTITUTION; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GHRELIN; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84907589400     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.09.012     Document Type: Article

References (40)

1. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
2. H.K. Berthold, E. Giannakidou, W. Krone, C.S. Mantzoros, and I. Gouni-Berthold The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes Clin Chim Acta 399 2009 112 116
3. D. Campa, B. Pardini, A. Naccarati, L. Vodickova, J. Novotny, and V. Steinke Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study BMC Gastroenterol 10 2010 112 117
4. A. Ceriello, and E. Motz Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 24 2004 816 823
5. H.J. Choi, Y.M. Cho, M.K. Moon, H.H. Choi, H.D. Shin, and H.C. Jang Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans J Clin Endocrinol Metab 91 11 2006 4657 4663
6. L. Dossus, J.D. McKay, F. Canzian, S. Wilkening, S. Rinaldi, and C. Biessy Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) Carcinogenesis 29 7 2008 360 366
7. M. Gröschl, R. Wagner, J. Dötsch, W. Rascher, and M. Rauh Preanalytical influences on the measurement of ghrelin Clin Chem 48 7 2002 1114 1116
8. S.M. Haffner, and H. Miettinen Insulin resistance implications for type II diabetes mellitus and coronary heart disease Am J Med 103 2 1997 152 162
9. J. Isgaard, and R. Granata Ghrelin in cardiovascular disease and atherogenesis Mol Cell Endocrinol 340 2011 59 64
10. B. Isomaa, P. Almgren, T. Tuomi, B. Forsén, K. Lahti, and M. Nissén Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 4 2001 683 689
11. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, and G. Sullivan Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 7 2000 2402 2410
12. T.R. Kiema, H. Kauma, A.O. Rantala, M. Lilja, A. Reunanen, and Y.A. Kesäniemi Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure Hypertension 28 1996 1070 1075
13. I. Kishimoto, T. Tokudome, H. Hosoda, M. Miyazato, and K. Kangawa Ghrelin and cardiovascular diseases J Cardiol 59 2012 8 13
14. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing asylated peptide from stomach Nature 402 1999 656 660
15. K. Kotani, N. Sakane, K. Saiga, S. Adachi, H. Mu, and Y. Kurozawa Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome Arch Med Res 37 2006 903 906
16. C. Langenberg, J. Bergstrom, C. Scheidt-Nave, J. Pfeilschfter, and E. Barret-Connor Cardiovascular death and the metabolic syndrome Diabetes Care 29 6 2006 1363 1369
17. C. Ledderose, S. Kreth, and A. Beiras-Fernandez Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function Recent Pat Endocr Metab Immune Drug Discov 5 2011 1 6
18. B. Liu, E.A. Garcia, and M. Korbonits Genetic studies on the ghrelin, growth hormone secretagoue receptor (GHSR) and ghrelin O-acy transferase (GOAT) genes Peptides 32 2011 2191 2207
19. N. Nagaya, M. Kojima, M. Uematsu, M. Yamagishi, H. Hosoda, and H. Oya Hemodynamic and hormonal effects of human ghrelin in healthy volunteers Am J Physiol Regul Integr Comp Physiol 280 2001 R1483 R1487
20. H. Okumura, N. Nagaya, M. Enomoto, E. Nakagawa, H. Oya, and K. Kangawa Vasodilatory effect of ghrelin, an endogenous peptide from the stomach J Cardiovasc Pharmacol 39 2002 779 783
21. P. Pajunen, P. Jousilahti, K. Borodulin, K. Harald, J. Tuomilehto, and V. Salomaa Body fat measured by a near-infrared interactance device as a predictor of cardiovascular events: the FINRISK′92 cohort Obesity 19 4 2011 848 852
22. C.J. Pemberton, H. Tokola, Z. Bagi, A. Koller, J. Pöntinen, and A. Ola Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion Am J Physiol Heart Circ Physiol 287 2004 H1522 H1529
23. S. Pöykkö, O. Ukkola, H. Kauma, M.J. Savolainen, and Y.A. Kesäniemi Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects Diabetologia 46 2003 455 458
24. S.M. Pöykkö, E. Kellokoski, S. Hörkkö, H. Kauma, Y.A. Kesäniemi, and O. Ukkola Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes Diabetes 52 2003 2546 2553
25. S.M. Pöykkö, E. Kellokoski, O. Ukkola, H. Kauma, M. Päivänsalo, and Y.A. Kesäniemi Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males J Intern Med 260 2006 43 52
26. L. Pulkkinen, O. Ukkola, M. Kolehmainen, and M. Uusitupa Ghrelin in diabetes and metabolic syndrome Intern J Peptid 2010 1 11
27. A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, and Y.A. Kesäniemi Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects J Intern Med 245 1999 163 174
28. M. Santaniemi, O. Ukkola, E. Malo, R. Bloigu, and Y.A. Kesäniemi Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin Eur J Prev Cardiol 2012 PMID: 23787794
29. D.R. Skibola, M.T. Smith, P.M. Bracci, A.E. Hubbard, L. Agana, and S. Chi Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma Cancer Epidemiol Biomarkers Prev 14 5 2005 1251 1256
30. N-P. Tang, L-S. Wang, L. Yang, H-J. Gu, H-J. Zhu, and B. Zhou Preproghrelin Leu72Met polymorphism in Chinese subjects with coronary artery disease and controls Clin Chim Acta 387 2008 42 47
31. N.A. Tritos, K.V. Kissinger, W.J. Manning, and P.G. Danias Association between ghrelin and cardiovascular indexes in healthy obese and lean men Clin Endocrinol 60 2004 60 66
32. O. Ukkola, and Y.A. Kesäniemi Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus J Intern Med 254 2003 391 394
33. O. Ukkola, T. Pääkkö, and Y.A. Kesäniemi Ghrelin and its promoter variant associated with cardiac hypertrophy J Hum Hypertens 26 7 2012 452 457
34. O. Ukkola, S. Pöykkö, M. Päivänsalo, and Y.A. Kesäniemi Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis Ann Med 40 2008 465 473
35. O. Ukkola, E. Ravussin, P. Jacobson, L. Pérusse, T. Rankinen, and M. Tschöp Role of ghrelin polymorphisms in obesity based on three different studies Obes Res 10 8 2002 782 791
36. O. Ukkola, E. Ravussin, P. Jacobson, E.E. Snyder, M. Chagnon, and L. Sjöström Mutations in the preproghrelin/ghrelin gene associated with obesity in humans J Clin Endocrinol Metab 86 8 2001 3996 3999
37. K. Wagner, K. Hemminki, E. Grzybowska, K. Rüdiger, B. Burwinkel, and P. Bugert Polymorphism in genes involved in GH1 release and their association with breast cancer risk Carcinogenesis 27 9 2006 1867 1875
38. M.P. Wajanrajch, I.S. Ten, J.M. Gertner, and R.L. Leibel Genomic organization of human ghrelin gene J Endocr Genet 1 2000 231 233
39. Y. Yano, K. Toshinai, T. Inokuchi, K. Kangawa, K. Shimada, and K. Kario Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients Atherosclerosis 204 2 2009 590 594
40. G. Zhang, X. Yin, Y. Qi, L. Pendyala, J. Chen, and D. Hou Ghrelin and cardiovascular diseases Curr Cardiol Rev 6 2010 62 70